HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M500024-MCP200v1 M500024-MCP200v2 4/8/1029    most recent Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sharma, A. Articles by Bharadwaj, D. Search for Related Content PubMed PubMed Citation Articles by Sharma, A. Articles by Bharadwaj, D. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 4:1029-1037, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Genetic Association, Post-translational Modification, and Protein-Protein Interactions in Type 2 Diabetes Mellitus^*,S

Amitabh Sharma^,,¶, Sreenivas Chavali^,,¶, Anubha Mahajan^,¶, Rubina Tabassum^,¶, Vijaya Banerjee^,¶, Nikhil Tandon^|| and Dwaipayan Bharadwaj^,**

From the Functional Genomics Unit, Institute of Genomics and Integrative Biology, Council of Scientific and Industrial Research (CSIR), Delhi 110 007 and the ^|| Department of Endocrinology, All India Institute of Medical Sciences, New Delhi 110 029, India

Type 2 diabetes mellitus is a complex disorder with a strong genetic component. Inherited complex disease susceptibility in humans is most commonly associated with single nucleotide polymorphisms. The mechanisms by which this occurs are still poorly understood. Here we focus on analyzing the effect of a set of disease-causing missense variations of the monogenetic form of Type 2 diabetes mellitus and a set of disease-associated nonsynonymous variations in comparison with that of nonsynonymous variations without any experimental evidence for association with any disease. Analysis of different properties such as evolutionary conservation status, solvent accessibility, secondary structure, etc. suggests that disease-causing variations are associated with extreme changes in the value of the parameters relating to evolutionary conservation and/or protein stability. Disease-associated variations are rather moderately conserved and have a milder effect on protein function and stability. The majority of the genes harboring these variations are clustered in or near the insulin signaling network. Most of these variations are identified as potential sites for post-translational modifications; certain predictions have already reported experimental evidence. Overall our results indicate that Type 2 diabetes mellitus may result from a large number of single nucleotide polymorphisms that impair modular domain function and post-translational modifications involved in signaling. Our emphasis is more on conserved corresponding residues than the variation alone. We believe that the approach of considering a stretch of peptide sequence involving a polymorphism would be a better method of defining the role of the polymorphism in the manifestation of this disease. Because most of the variations associated with the disease are rare, we hypothesize that this disease is a "mosaic model" of interaction between a large number of rare alleles and a small number of common alleles along with the environment, which is little contrary to the existing common disease common variant model.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

eLetters: